Tscan Therapeutics, Inc.
TCRX
Revenue
536.00k
▼-30.00k▼-5.30%
3 Months ChangeAssets
374.87M
▲134.04M▲55.66%
3 Months ChangeLiabilities
119.65M
▲1.79M▲1.51%
3 Months ChangeFree Cash Flow
-29.97M
▼-5.55M▼-22.71%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-11-01
Form 8-K
ID: 0001193125-24-249124
2024-08-12
Form 10-Q
ID: 0000950170-24-095066
2024-08-12
Form 8-K
ID: 0000950170-24-095063
2024-06-14
Form 8-K
ID: 0001193125-24-161151
2024-05-13
Form 10-Q
ID: 0000950170-24-058198
2024-05-13
Form 8-K
ID: 0000950170-24-058194
2024-04-17
Form 8-K
ID: 0001193125-24-098509
2024-04-16
Form 8-K
ID: 0001193125-24-097764
2024-04-08
Form 8-K
ID: 0001193125-24-089164
2024-03-06
Form 8-K
ID: 0000950170-24-026868